- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02655172
Have a Good Grasp of the Worldthe World (GRASP)
September 5, 2019 updated by: Centre Hospitalier Universitaire de Saint Etienne
Study on the Links Between Action and Perception in Schizophrenia, " Have a Good Grasp of the World "
Brief Summary: In schizophrenia, dislocation of psychic functions involving a loss of contact with reality is frequently found.
A fragmentation of motor and sensory perceptions could be held responsible.
However, automatic integration between perception and action is the necessary condition to be in "relationship with the world."
Affordance is the experimental link between object perception and potentially associated actions (Gibson, 1977, 1979) explored by Stimulus Response Compatibility (SRC) paradigm.
With Tucker & Ellis sensory motor compatibility task (1998), with a modified response device (responses given with grasp), we study the impact of motor activation on these affordance effects.
In this study, a group of controls will also be included in order to understand, as precisely as possible, the mechanisms involved (i.e., interference between the perception of the object and the response gesture).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Schizophrenic patients will perform: Alert TEA, (Zimmermann and Fimm, 2005), Edinburgh laterality questionnaire (Oldfield, 1971), IQ test (IQ: PM38, Raven, 1960), and the PANSS (Positive and Negative Syndrome Scale, Kay et al., 1987).
Controls will only perform the laterality questionnaire.
Then all will perform the affordance task, in which photographs of 20 objects of everyday life, typically graspable with one hand, are presented in 4 orientations.
Participants have to respond in a graspable device, as quickly as possible, if the object is presented upright or inverted.
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-etienne, France, 42055
- CHU Saint-Etienne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
For patients:
- a DSM-IV diagnosis of schizophrenia (men or women),
- no change in antipsychotic medication and clinical status within four weeks prior to the study
- For patients and control group • Age ≥ 18 years et ≤ 55 years
Exclusion Criteria:
- History of head trauma,
- neurological disease with cerebral repercussion or not stabilized serious physical illness;
- psychotropic medication
- disorders related to the use of a psychoactive substance (abuse, dependence or withdrawal);
Exclusion Criteria:
For patients:
• IQ < 70
For patients and control group
- History of head trauma,
- neurological disease with cerebral repercussion or not stabilized serious physical illness;
- psychotropic medication
- disorders related to the use of a psychoactive substance (abuse, dependence or withdrawal);
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients
patients suffering schizophrenic disorders and who will perform cognitive tasks + PANSS+ IQ
|
Patients will perform different tasks: reaction time (Alert TEA, Zimmermann and Fimm, 2005), Edinburgh laterality questionnaire (Oldfield,1971), IQ test (IQ: PM38, Raven, 1960), and the PANSS (Positive and Negative Syndrome Scale (Kay et al., 1987) + the experimental task (affordance task with graspable device)
|
|
Active Comparator: Control group
healthy patients who will perform cognitive tasks
|
Healthy volunteers will perform only Edinburgh laterality questionnaire (Oldfield, 1971) + the experimental task (affordance task with graspable device).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
response time
Time Frame: day 1
|
The gain provided by the compatible vs incompatible conditions (ms response time)
|
day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Anne GROSSELIN, MD, CHU Saint-Etienne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 24, 2016
Primary Completion (Actual)
April 3, 2019
Study Completion (Actual)
April 3, 2019
Study Registration Dates
First Submitted
January 12, 2016
First Submitted That Met QC Criteria
January 12, 2016
First Posted (Estimate)
January 13, 2016
Study Record Updates
Last Update Posted (Actual)
September 6, 2019
Last Update Submitted That Met QC Criteria
September 5, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1508205
- 2015-A01939-40 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenic Disorders
-
AstraZenecaCompletedSchizophrenic DisorderBulgaria, Russian Federation, Romania, South Africa, Greece, Philippines, India, Indonesia
-
Shanghai Mental Health CenterStanley Medical Research InstituteWithdrawnCognitive Impairment | Schizophrenic DisorderChina
-
Shalvata Mental Health CenterBar-Ilan University, IsraelUnknownSchizophrenic PatientsIsrael
-
University of WashingtonRecruitingSchizophrenic Spectrum DisorderGhana
-
Tanta UniversityCompleted
-
JanuelUnknownThe Impact of Stigma on the Quality of Life of People With Schizophrenic Disorders and Their Siblings
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Northeast Normal UniversityCompletedSchizophrenic PatientsChina
-
Northeast Normal UniversityCompletedSchizophrenic PatientsChina
-
US Department of Veterans AffairsCompletedSchizophrenia | Schizophrenic DisorderUnited States
Clinical Trials on cognitive tasks + PANSS+ IQ
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedBipolar Affective DisorderFrance
-
Nantes University HospitalCompleted
-
University Hospital, GrenobleCommissariat A L'energie Atomique; Laboratoire de Psychologie et NeuroCognitionCompleted
-
Universidade Federal do Rio Grande do NorteConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
University Hospital, GrenobleGrenoble Institut des NeurosciencesRecruitingCognition | Focal Brain InjuryFrance
-
Centre Hospitalier St AnneActive, not recruitingPsychiatric Diseases | Neurological Diseases or Conditions | Candidates for Deep Brain Stimulation | Candidates for Invasive S-EEG | Candidates for Awake SurgeryFrance
-
Centre Hospitalier St AnneCompleted
-
University of California, Los AngelesDanone Nutricia ResearchCompleted
-
Gloucestershire Hospitals NHS Foundation TrustCompletedCognitive Impairment | Coginitive AssessmentUnited Kingdom